Histologic Variations and Immunohistochemical Features of Metastatic Clear Cell Renal Cell Carcinoma
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background: Due to advancements in treatment of metastatic and advanced renal cell carcinoma (RCC), it has become increasingly important to diagnose metastatic RCC and the specific subtype. In this study, we investigated the diverse histologic features of metastatic clear cell renal cell carcinoma (CCRCC) cases in comparison with corresponding primary lesions. Methods: We identified 119 metastatic CCRCC cases from 81 corresponding primary lesions diagnosed between 1995 and 2010 and evaluated the diverse histologic and immunohistochemical features of these lesions. Results: A total of 44 primary lesions (54.3%) had a non-clear cell component in addition to a typical clear cell component. Of the 119 metastatic lesions, 63 lesions (52.9%) contained a non-clear cell component, and 29 metastatic lesions were composed of a non-clear cell component only. Rhabdoid features were the most frequent non-clear cell histology among the metastatic lesions. Metastatic CCRCCs mainly showed positive CD10 and epithelial membrane antigen staining and negative cytokeratin 7 staining. Conclusions: Metastatic CCRCC commonly showed a variety of histologic features. If there is a difficulty to diagnose metastatic CCRCC due to a variety of histologic features or small biopsy specimen, histologic review of the primary lesion and immunohistochemical analysis can help determine the correct diagnosis.
Abstract
Background: Due to advancements in treatment of metastatic and advanced renal cell carcinoma (RCC), it has become increasingly important to diagnose metastatic RCC and the specific subtype. In this study, we investigated the diverse histologic features of metastatic clear cell renal cell carcinoma (CCRCC) cases in comparison with corresponding primary lesions. Methods: We identified 119 metastatic CCRCC cases from 81 corresponding primary lesions diagnosed between 1995 and 2010 and evaluated the diverse histologic and immunohistochemical features of these lesions. Results: A total of 44 primary lesions (54.3%) had a non-clear cell component in addition to a typical clear cell component. Of the 119 metastatic lesions, 63 lesions (52.9%) contained a non-clear cell component, and 29 metastatic lesions were composed of a non-clear cell component only. Rhabdoid features were the most frequent non-clear cell histology among the metastatic lesions. Metastatic CCRCCs mainly showed positive CD10 and epithelial membrane antigen staining and negative cytokeratin 7 staining. Conclusions: Metastatic CCRCC commonly showed a variety of histologic features. If there is a difficulty to diagnose metastatic CCRCC due to a variety of histologic features or small biopsy specimen, histologic review of the primary lesion and immunohistochemical analysis can help determine the correct diagnosis.
참고문헌 (30)
- Ljungberg B, "Prognostic significance of the Heidelberg classification of renal cell carcinoma", Eur Urol, 36, pp.565~569 (1999)
- Lam JS, "Surveillance following radical or partial nephrectomy for renal cell carcinoma", Curr Urol Rep, 6, pp.7~18 (2005)
- Chow WH, "Rising incidence of renal cell cancer in the United States", JAMA, 281, pp.1628~1631 (1999)
- Reeves DJ, "Treatment of metastatic renal cell carcinoma", Cancer Chemother Pharmacol, 64, pp.11~25 (2009)
- Tamaskar I, "Update on novel agents in renal cell carcinoma", Expert Rev Anticancer Ther, 9, pp.1817~1827 (2009)
- Di Lorenzo G, "The therapy of kidney cancer with biomolecular drugs", Cancer Treat Rev, 36(Suppl 3), pp.16~20 (2010)
- Eble JN, "Pathology and genetics of tumours of the urinary system and male genital organs", pp.12~39 (2004), IARC Press
- Humphrey PA, "Sarcomatoid renal cell carcinoma", J Urol, 188, pp.601~602 (2012)
- Cheville JC, "Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome", Am J Surg Pathol, 28, pp.435~441 (2004)
- Mian BM, "Prognostic factors and survival of patients with sarcomatoid renal cell carcinoma", J Urol, 167, pp.65~70 (2002)
- Shuch B, "Impact of pathological tumour characteristics in patients with sarcomatoid renal cell carcinoma", BJU Int, 109, pp.1600~1606 (2012)
- Gökden N, "Renal cell carcinoma with rhabdoid features", Am J Surg Pathol, 24, pp.1329~1338 (2000)
- Kuroiwa K, "Renal cell carcinoma with rhabdoid features: an aggressive neoplasm", Histopathology, 41, pp.538~548 (2002)
- Chapman-Fredricks JR, "Adult renal cell carcinoma with rhabdoid morphology represents a neoplastic dedifferentiation analogous to sarcomatoid carcinoma", Ann Diagn Pathol, 15, pp.333~337 (2011)
- Leroy X, "Renal cell carcinoma with rhabdoid features: an aggressive neoplasm with overexpression of p53", Arch Pathol Lab Med, 131, pp.102~106 (2007)
- Shannon B, "Adult rhabdoid renal cell carcinoma", Arch Pathol Lab Med, 126, pp.1506~1510 (2002)
- Weeks DA, "Rhabdoid tumor of kidney: a report of 111 cases from the National Wilms’ Tumor Study Pathology Center", Am J Surg Pathol, 13, pp.439~458 (1989)
- Truong LD, "Immunohistochemical diagnosis of renal neoplasms", Arch Pathol Lab Med, 135, pp.92~109 (2011)
- Sangoi AR, "The use of immunohistochemistry in the diagnosis of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2, hKIM-1, RCCma, and CD10", Adv Anat Pathol, 17, pp.377~393 (2010)
- Abel EJ, "Limitations of preoperative biopsy in patients with metastatic renal cell carcinoma: comparison to surgical pathology in 405 cases", BJU Int, 110, pp.1742~1746 (2012)
- Abel EJ, "Percutaneous biopsy of primary tumor in metastatic renal cell carcinoma to predict high risk pathological features: comparison with nephrectomy assessment", J Urol, 184, pp.1877~1881 (2010)
- Humphrey PA, "Renal cell carcinoma with rhabdoid features", J Urol, 186, pp.675~676 (2011)
- Allory Y, "Profiling and classification tree applied to renal epithelial tumours", Histopathology, 52, pp.158~166 (2008)
- Liu L, "Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis", Arch Pathol Lab Med, 131, pp.1290~1297 (2007)
- Skinnider BF, "Distribution of cytokeratins and vimentin in adult renal neoplasms and normal renal tissue: potential utility of a cytokeratin antibody panel in the differential diagnosis of renal tumors", Am J Surg Pathol, 29, pp.747~754 (2005)
- Avery AK, "Use of antibodies to RCC and CD10 in the differential diagnosis of renal neoplasms", Am J Surg Pathol, 24, pp.203~210 (2000)
- Rivera AL, "Useful immunohistochemical markers in differentiating hemangioblastoma versus metastatic renal cell carcinoma", Neuropathology, 30, pp.580~585 (2010)
- Bakshi N, "Expression of renal cell carcinoma antigen (RCC) in renal epithelial and nonrenal tumors: diagnostic implications", Appl Immunohistochem Mol Morphol, 15, pp.310~315 (2007)
- Ozcan A, "PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison", Arch Pathol Lab Med, 136, pp.1541~1551 (2012)
- Sharma SG, "The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features", Appl Immunohistochem Mol Morphol, 18, pp.494~498 (2010)